Jingke Kangyang completes ￥100M Pre-A round to boost smart upgrade of cross-border E-commerce supply base
Recently, Jingke Kangyang Industrial Group, a technology-driven enterprise in the health and wellness sector, announced the completion of a Pre-A round financing worth tens of millions. This round was led by Beijing Chunyu Capital. The funds will primarily be used to upgrade the product research and development system, construct an intelligent production base, and enhance the innovative "e-commerce + financial services" platform.
Jingke Kangyang was co-founded by experts and senior executives with backgrounds from the Chinese Academy of Sciences, Universities of Traditional Chinese Medicine, top-tier hospitals in China, and listed companies. Addressing critical industry pain points such as severe product homogenization, lack of consumer trust, insufficient personalization of health needs, and poor integration of online and offline channels, the company leverages top-tier scientific research resources and big data technology to build an innovative "R&D-quality control-service" full-chain system.
Currently, Jingke Kangyang focuses on three core segments: weight loss and slimming, women's blood and qi (vital energy) replenishment, and sugar reduction and regulation. Its products achieve an average daily sales volume of nearly one million, with annual sales having surpassed the 100 million milestone.
Distinct from traditional health product providers, Jingke Kangyang innovates through an "e-commerce + financial services" model, integrating online and offline resources to offer consumers customized health solutions. Jingke Kangyang plans to strategically expand its product lines into areas such as sleep health, liver and stomach care, and nourishing wellness, developing new categories including sleep-aid monitoring devices and personalized medicinal paste formulations, thereby building a differentiated product matrix.
Currently, Jingke Kangyang has established a tri-location collaborative structure comprising its Beijing management department, Yiwu operations department, and Jining operations center. With a team of over one hundred employees, its market coverage extends to major cities across China as well as international markets.
According to Chunyu Capital, the core investment rationale for Jingke Kangyang lies in its triple advantages of "strong scientific research background, digital operational capabilities, and a sustainable business model." The proceeds from this round of financing will be allocated to the following specific areas:
Strengthen R&D investment to expand new product categories such as sleep health and liver care;
Construct an intelligent production base to enhance supply chain efficiency;
Deepen sales channel deployment in China and internationally;
Reinforce brand building to elevate market awareness.